![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 215/22 | |
A61K 31/47 | |||
A61P 35/00 |
(11) | Number of the document | 3274332 |
(13) | Kind of document | T |
(96) | European patent application number | 16710997.4 |
Date of filing the European patent application | 2016-03-22 | |
(97) | Date of publication of the European application | 2018-01-31 |
(45) | Date of publication and mention of the grant of the patent | 2018-12-19 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2016/056267 |
Date | 2016-03-22 |
(87) | Number | WO 2016/150966 |
Date | 2016-09-29 |
(30) | Number | Date | Country code |
15160869 | 2015-03-25 | EP |
(72) |
STEFINOVIC, Marijan, AT
SCHREINER, Erwin, Paul, AT
|
(73) |
Sandoz AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(54) | CRYSTALLINE FORMS OF CABOZANTINIB PHOSPHATE AND CABOZANTINIB HYDROCHLORIDE |
CRYSTALLINE FORMS OF CABOZANTINIB PHOSPHATE AND CABOZANTINIB HYDROCHLORIDE |